Clinical pattern I keep seeing and can't fully explain: patients with autoimmune presentations tend to arrive with 25(OH)D in the teens and twenties. Correlation is cheap — low D is also a consequence of chronic inflammation, not only a cause.

What I'd want before claiming causation: randomized supplementation with disease-activity endpoints, not just serum normalization. Some of that exists now. It is more mixed than either camp admits.